Affective Disorders Treatments Flashcards

1
Q

Depression: Screening Questions:

A
  • during the last month have you
    often been feeling down,
    depressed or hopeless?
  • during the last month have you
    often been bothered by having little
    interest or pleasure in doing things?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

General Approach to Depression Management:

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Psychoeducation:

A
  • nature of depressive illness
  • talk about concerns the person
    may have about their presenting
    problems
  • day to day things that can impact
    on mental health: work, family,
    sleep, drugs
  • sleep hygiene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Psychosocial Interventions in Depression:

A
  • regular exercise -> structured
    group physical activity programme
  • befriending services
  • local support groups
  • social prescriber
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Psychological Interventions for Depression:

A

Low Intensity:
- CBT
- guided self help book
- group CBT

High Intensity:
- individual CBT
- other individual therapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CBT:

A
  • involves linking thoughts, feelings
    and behaviours
  • focuses on maladaptive thinking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why do antidepressant have a delayed response time?

A
  • downregulation of receptors due to
    the increased neurotransmitter
    release: via alterations in gene
    expression
  • neurogenesis/synaptic plasticity in
    the hippocampus and prefrontal
    cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Principles of Antidepressant Treatment:

A
  • short-term response rates in
    clinical trials:
    • 50% on active treatment
    • 30% on placebo
  • SSRIs are first line
  • onset of therapeutic effect delayed
  • continue for at least 6 months:
    high rate of relapse when stopped
    before then
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Abbrieviations:
- SSRIs
- SNRIs
- TCA
- MAOIs

A
  • selective serotonin reuptake
    inhibitors
  • serotonin and noradrenaline
    reuptake inhibitors
  • tricyclic antidepressants
  • monoamine oxidase inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Core Drug: Fluoxetine: Drug Class:

A
  • antidepressant
  • SSRIs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Core Drug: Fluoxetine: Mechanism of Action:

A
  • SSRIs
  • increase amount of serotonin in
    the synapse by blocking its
    reuptake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Core Drug: Fluoxetine: Side Effects:

A
  • usually improve within a few weeks

***hyponatremia

  • nausea and loss of appetite
  • diarrhoea
  • loss of libido
  • insomnia
  • agitation
  • anxiety
  • headaches
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Core Drug: Fluoxetine/SSRIs: Main Interaction:

A

NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Venlafaxine/ Duloxetine are

A
  • SNRIs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Key differences between SNRIs and SSRIs

A
  • SNRIs are more toxic in overdose
  • similar adverse side effects
    (nausea, GI, headache, anxiety,
    hyponatremia)
  • caution in hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Core Drug: Amitriptyline: Drug Class:

A
  • antidepressant
  • Tricyclic antidepressants (TCAs)
17
Q

Core Drug: Amitriptyline: Mechanism of Action:

A
  • block monoamine reuptake
  • mostly serotonin and
    noradrenaline
  • less affect dopamine
18
Q

Core Drug: Amitriptyline: Side Effects:

A
  • sedation
  • confusion
  • loss of motor coordinatinon (**falls
    in the elderly)
  • anticholinergic effects: dry mouth,
    blurred vision, constipation, urinary
    retention
  • cardiotoxicity in overdose
19
Q

Anticholinergic Effects:

A
  • pupil dilation
  • blurred vision
  • dry mouth
  • constipation
  • urinary retention
20
Q

Core Drug: Amitriptyline: Uses:

A
  • avoid with elderly
  • sometimes used for neuropathic
    pain
  • avoided generally due to
    anticholinergic effects
21
Q

Antidepressants: Monoamine Oxidase Inhibitors:

A
  • irreversible: phenelzene
  • reversible: moclobemide
  • prevents the breakdown of
    monamines by the enzyme
    monamine oxidase: increases 5-Ht,
    noradrenaline and dopamine
    content
  • tyramine is harmless normally
    produced during cheese
    fermentation
  • tyramine is normally metabolised
    by MAO in gut wall and liver
  • MOAIs block metabolism of
    tyrosine so that it is absorbed:
    sympathomimetic effects can lead
    to hypertensive crisis and
    intracranial haemorrhage
  • drug interactions -> can not be
    prescribed with other
    antidepressants
22
Q

Monoamine Receptor Antagonists:

A
  • mirtazapine
  • blocks alpha 2 adrenoreceptors,
    and several 5-HT receptors
  • blocks histamine H1 receptors
  • side effects include sedation and
    weight gain
23
Q

83 year old lady prescribed citalopram several weeks ago presents with sudden onset confusion. She has a delirium related to the citalopram – what is the likely cause?

A

Hyponatraemia

24
Q

Antidepressants and hyponatremia:

A
  • all antidepressants can cause
    hyponatremia but SSRIs are worst
  • can cause delirium, seizures,
    potentially fatal
  • more common in older people,
    drug interactions
  • monitoring necessary
25
Q

Antidepressant Withdrawal Symptoms:

A
  • dizziness
  • anxiety
  • insomnia and vivid dreams
  • general malaise
  • irritability
  • headache
  • electric shock sensations in arms
    and legs
  • low mood and suicidal thoughts
  • agitation
26
Q

Antidepressant withdrawal symptoms does not mean they are addictive.

A
  • no sensitisation no higher dose
    needed for same effect
  • no cravings
  • temporary deficiency of synaptic
    serotonin may need time for down-
    regulated receptors to adjust (days-
    weeks)
  • warn patients before starting
  • reduce and stop slowly
27
Q

Core Drug: Lithium: Drug Use:

A

Mood stabaliser

can be used in depression and bipolar disorder

28
Q

Core Drug: Lithium: Depression:

A
  • lithium augmentation
  • lithium added to antidepressant
  • can be very effective when other
    treatments have not been
  • narrow therapeutic window
    requires monitoring
  • drug interactions
29
Q

Core Drug: Lithium: Mechanism of Action:

A
  • monovalent cation
  • similar way to sodium
  • not fully understood
30
Q

Core Drug: Lithium: Adverse Effects:

A
31
Q

Core Drug: Lithium: Monitoring:

A
  • frequent plasma lithium levels
    whilst establishing dose
  • 6 monthly: lithium level, renal
    function, thyroid function
  • additionally tests if physically
    unwell or possibly toxic
32
Q

Depression: Electroconvulsive Therapy:

A
  • electric current applied to skull of
    anaesthetised patient
  • produces a seizure
  • motor effects of seizure prevented
    using a muscle relaxant
  • used in severe depression when
    life is threatened by not eating,
    drinking or intense suicidal ideation
  • lack of response to other
    treatments
33
Q

Management of Unipolar depression:

A
  • psychoeducation
  • psychosocial interventions
  • psychological interventions (low
    and high intensity)
  • antidepressants
  • antipsychotics for severe
    depression with psychosis
  • ECT for severe depression and
    immediate risk
  • MDT support from specialist
    services
34
Q

General Approach to the Management of Bipolar Disorder:

A
  • treatment of acute mood episode:
    depression or mania
  • maintenance treatment to
    promote mood stability
  • relapse prevention
  • often managed in specialist mental
    health services
35
Q

Bipolar Disorder: Acute Mania: Treatment:

A
  • urgent response essential
  • stop antidepressants
  • if not any treatment yet, start
    antipsychotic
  • if on treatment:
    • check compliance and lithium
      check levels
    • consider adding or changing
      antipsychotic
  • benzodiazepines may be used as
    an adjunctive (additional
    treatment) to restore overactivity,
    restore sleep

antipsychotic will treat most wuickly but if on lithium then check levels

36
Q

Maintenance Pharmacological Treatment in Bipolar Disorder:

A
  • lithium is first line maintenance
    treatment
  • anticonvulsants: valproate most
    common
  • relapse prevention work
37
Q

Bipolar Disorder: Depression: Management:

A
  • similar to unipolar depression
    (including psychological and
    psychosocial interventions)
  • caution due to risk of manic switch;
    drug treatment of depression can
    flip into hypomania or mania
  • often need to combine an
    antidepressant with a mood
    stabiliser
38
Q

Management of Bipolar Affective Disorder:

A
  • treat manic: urgent, antipsychotic,
    lithium levels
  • treat depression: antidepressant,
    mood stabaliser to prevent manic
    switch
  • maintenance treatment to prevent
    further episodes:
    • Lithium first line, then valproate,
      antipsychotics
    • relapse prevention work (MDT
      support)